Company Profile

Cash Flow

BETA DRUGS LTD.

NSE : BETABSE : ISIN CODE : INE351Y01019Industry : Pharmaceuticals & DrugsHouse : Private

BSE0.000 (0 %)

PREV CLOSE ( ) NA

OPEN PRICE ( ) 0.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 0

TODAY'S LOW / HIGH ( )0.00 0.00

52 WK LOW / HIGH ( )0 0

NSE1879.0025.25 (+1.36 %)

PREV CLOSE( ) 1853.75

OPEN PRICE ( ) 1850.00

BID PRICE (QTY) 1880.00 (105)

OFFER PRICE (QTY) 1895.90 (105)

VOLUME 3465

TODAY'S LOW / HIGH( ) 1850.00 1899.95

52 WK LOW / HIGH ( )1047.62 2215.24

Particulars

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Profit Before Tax

487.54

410.57

343.01

159.51

119.72

Adjustment

-42.47

20.20

50.98

65.42

24.01

Changes In working Capital

-135.77

-196.94

-97.72

-38.93

-59.59

Cash Flow after changes in Working Capital

309.30

233.83

296.28

186.00

84.14

Cash Flow from Operating Activities

309.30

233.83

296.28

186.00

84.14

Cash Flow from Investing Activities

-139.72

-190.69

-217.55

-58.48

-150.55

Cash Flow from Financing Activities

-74.90

-24.74

-9.74

-77.14

87.26

Net Cash Inflow / Outflow

94.69

18.40

68.99

50.38

20.85

Opening Cash & Cash Equivalents

191.64

173.24

104.25

53.87

33.02

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

286.33

191.64

173.24

104.25

53.87